Xing Li

11.6k total citations · 1 hit paper
418 papers, 8.1k citations indexed

About

Xing Li is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Xing Li has authored 418 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Oncology, 86 papers in Molecular Biology and 85 papers in Epidemiology. Recurrent topics in Xing Li's work include Liver Disease Diagnosis and Treatment (21 papers), Inflammatory Biomarkers in Disease Prognosis (19 papers) and MicroRNA in disease regulation (18 papers). Xing Li is often cited by papers focused on Liver Disease Diagnosis and Treatment (21 papers), Inflammatory Biomarkers in Disease Prognosis (19 papers) and MicroRNA in disease regulation (18 papers). Xing Li collaborates with scholars based in China, United States and Hong Kong. Xing Li's co-authors include Hailin Tang, Joseph Sodroski, Qu Lin, Zhan‐Hong Chen, Xinhua Xie, Xiangyuan Wu, Hualiang Lin, Xiaokun Ma, Weilin Zeng and Tao Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Xing Li

398 papers receiving 8.0k citations

Hit Papers

Dual GIP and GLP-1 recept... 2025 2026 2025 5 10 15

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Xing Li 2.1k 1.6k 1.5k 1.5k 1.3k 418 8.1k
Elizabeta Nemeth 3.1k 1.4× 1.3k 0.8× 922 0.6× 1.4k 1.0× 1.3k 1.0× 233 28.8k
Xiaoyan Wang 3.1k 1.4× 1.8k 1.1× 1.8k 1.2× 868 0.6× 1.1k 0.8× 333 8.0k
Karen Messer 2.3k 1.1× 1.0k 0.6× 1.3k 0.9× 897 0.6× 1.0k 0.8× 212 8.1k
Sheng Wei 1.8k 0.8× 1.7k 1.1× 1.7k 1.1× 885 0.6× 623 0.5× 314 9.0k
Hai‐Feng Pan 3.1k 1.4× 3.3k 2.0× 1.1k 0.7× 1.1k 0.7× 1.6k 1.2× 456 10.4k
Wenqing Li 3.7k 1.7× 2.4k 1.5× 1.7k 1.1× 1.0k 0.7× 1.3k 1.0× 377 11.2k
Lijun Zhang 4.3k 2.0× 944 0.6× 1.5k 1.0× 1.9k 1.3× 1.3k 1.0× 597 11.8k
Xiao Liu 5.2k 2.4× 1.8k 1.1× 1.2k 0.8× 1.5k 1.0× 2.3k 1.7× 546 11.6k
Qiong Zhang 5.3k 2.5× 1.8k 1.1× 1.2k 0.8× 1.1k 0.7× 2.3k 1.7× 457 11.0k
Feng Chen 5.1k 2.4× 934 0.6× 1.6k 1.1× 1.4k 1.0× 2.5k 1.9× 523 11.4k

Countries citing papers authored by Xing Li

Since Specialization
Citations

This map shows the geographic impact of Xing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing Li more than expected).

Fields of papers citing papers by Xing Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing Li. The network helps show where Xing Li may publish in the future.

Co-authorship network of co-authors of Xing Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xing Li. A scholar is included among the top collaborators of Xing Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xing Li. Xing Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gong, Wenyu, Lu Gan, Yikun Zhu, et al.. (2025). Dual GIP and GLP-1 receptor agonist tirzepatide alleviates hepatic steatosis and modulates gut microbiota and bile acid metabolism in diabetic mice. International Immunopharmacology. 147. 113937–113937. 16 indexed citations breakdown →
2.
Liu, C. & Xing Li. (2024). Identification of hub genes and establishment of a diagnostic model in tuberculosis infection. AMB Express. 14(1). 36–36. 3 indexed citations
3.
Xi, Yu, Guo‐Ping Jiang, Lei Zhou, et al.. (2024). Response of bacterial ecological and functional properties to anthropogenic interventions during maturation of mine sand soil. The Science of The Total Environment. 938. 173354–173354. 2 indexed citations
6.
Chen, Xiaolan, et al.. (2023). Case report: Two cases of Poirier-Bienvenu neurodevelopmental syndrome and review of literature. Frontiers in Pediatrics. 11. 967701–967701. 4 indexed citations
7.
Li, Xing, et al.. (2023). The effect of internal salary incentives based on insurance payment on physicians’ behavior: experimental evidence. BMC Health Services Research. 23(1). 1410–1410. 1 indexed citations
8.
Zhang, Yuehua, Wen Li, Zheng Wu, et al.. (2023). FBXO22 Mediates the NGF/TRKA Signaling Pathway in Bone Metastases in Prostate Cancer. American Journal Of Pathology. 193(9). 1248–1266. 12 indexed citations
9.
Li, Xing, et al.. (2023). Controllable release of self-assembled reduction-sensitive paclitaxel dimer prodrug and tetrandrine nanoparticles promotes synergistic therapy against multidrug-resistant cancer. Biochimica et Biophysica Acta (BBA) - General Subjects. 1867(7). 130362–130362. 2 indexed citations
10.
Li, Xing, et al.. (2023). A novel PDT: 5-aminolevulinic acid combined 450 nm blue laser photodynamic therapy significantly promotes cell death of HR-HPV infected cells. Artificial Cells Nanomedicine and Biotechnology. 51(1). 22–32. 6 indexed citations
12.
Zhao, Tong, et al.. (2022). The Association Between GC Gene Polymorphisms and Metabolic Syndrome in Chinese Rural Population: A Case–Control Study. Dove Medical Press (Taylor and Francis Group). 5 indexed citations
13.
Liu, Nan, et al.. (2022). Scabies Knowledge Among Undergraduate Nursing Students in China: A Questionnaire Survey. SHILAP Revista de lepidopterología. 2 indexed citations
14.
Wang, Zehao, Lu Yang, Peng Wu, et al.. (2022). The circROBO1/KLF5/FUS feedback loop regulates the liver metastasis of breast cancer by inhibiting the selective autophagy of afadin. Molecular Cancer. 21(1). 29–29. 118 indexed citations
15.
Meng, Lin, Yueqi Zhao, Wenhuan Bu, et al.. (2020). Bone mesenchymal stem cells are recruited via CXCL8‐CXCR2 and promote EMT through TGF‐β signal pathways in oral squamous carcinoma. Cell Proliferation. 53(8). e12859–e12859. 26 indexed citations
16.
Wang, Jun, Xing Li, Jun Pu, et al.. (2019). Association between Gamma-Glutamyl Transferase and Coronary Atherosclerotic Plaque Vulnerability: An Optical Coherence Tomography Study. BioMed Research International. 2019. 1–11. 5 indexed citations
17.
Liu, Yufeng, Michela Perego, Qiang Xiao, et al.. (2019). Lactoferrin-induced myeloid-derived suppressor cell therapy attenuates pathologic inflammatory conditions in newborn mice. Journal of Clinical Investigation. 129(10). 4261–4275. 62 indexed citations
18.
He, Yumei, Xing Li, Michela Perego, et al.. (2018). Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammation. Nature Medicine. 24(2). 224–231. 157 indexed citations
19.
Lei, Aihua, Qiong Yang, Xing Li, et al.. (2016). Atorvastatin promotes the expansion of myeloid‐derived suppressor cells and attenuates murine colitis. Immunology. 149(4). 432–446. 38 indexed citations
20.
Jiang, Lina, Shaowei Chen, Xueyan Zheng, et al.. (2015). [Detection of serum antibodies against Japanese encephalitis virus in bats in Hainan and Guangdong Provinces of China].. PubMed. 35(5). 720–3. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026